Vaderis Therapeutics: Funding, Investors & Team (Oct 2026)
Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.
Vaderis Therapeutics has raised $152M across 1 funding round on record, the most recent a Series B of $152M announced in Aug 2026.
That round is above the $3.8M median round size for Switzerland companies tracked on FundedIQ over the last two years.
Vaderis Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Vaderis Therapeutics Funding Rounds
Vaderis Therapeutics Investors
8 investors are recorded in total; the 5 named above are those the record identifies.
Vaderis Therapeutics Founders and Leadership Team
Contact details for the Vaderis Therapeutics team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Vaderis Therapeutics Funding in Context
Vaderis Therapeutics' latest round of $152M is above the median round in Switzerland. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vaderis Therapeutics in Biotechnology and Basel
Companies Similar to Vaderis Therapeutics
One interface for every open source model
Food Founders Studio is a venture studio that builds and launches B2B food tech ventures.
Terra Preta is a platform for decentralized biochar production that removes carbon and restores soil health.
Bee People taps into the ingenuity of bees to produce natural health supplements and superfoods.
Prevision Medicine AG is a oncology company that provides cancer therapy, tests living cancer cells, and…
smartNsales is the AI workspace for FMCG teams, connecting key accounts, activations, trade investment,…
ETFbook is a platform that specializes in providing information and analysis on exchange-traded funds (ETFs).…
Embodied AI develops robotic manipulators and AI models for human-robot interaction.
Preventive healthcare platform that equips people with personalized insights and expert guidance for…
Ferm Labs develops bioprocessing-based clean-label flavor ingredients for food manufacturers.
Fusionality is a Swiss fusion-technology company focused on measurement, control, and data systems for fusion…
Jaipur Robotics develops computer vision and artificial intelligence solutions for waste-to-energy plants.
Vaderis Therapeutics Funding FAQs
What does Vaderis Therapeutics do?
Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.
How much funding has Vaderis Therapeutics raised?
Vaderis Therapeutics has raised $152M across 1 round on record. The most recent is a Series B of $152M announced in Aug 2026.
When did Vaderis Therapeutics last raise funding?
Vaderis Therapeutics' most recent funding round on record is a Series B of $152M, announced in Aug 2026.
Who has invested in Vaderis Therapeutics?
Investors on record for Vaderis Therapeutics include TCG Crossover, Perceptive Advisors, EQT Life Sciences, Medicxi, Omega Funds. FundedIQ records 8 investors in total.
Who is the CEO of Vaderis Therapeutics?
Azmi Nabulsi is listed as President & Chief Executive Officer at Vaderis Therapeutics.
Where is Vaderis Therapeutics headquartered?
Vaderis Therapeutics is based in Basel, Switzerland.
How many employees does Vaderis Therapeutics have?
Vaderis Therapeutics is in the 11-50 employee band.
When was Vaderis Therapeutics founded?
Vaderis Therapeutics was founded in 2019.
About FundedIQ's Vaderis Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vaderis Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.